HF/Transplantation

Top Story

Hypertension significant cause of CVD events in black adults

Hypertension significant cause of CVD events in black adults
October 23, 2019
FDA News

FDA expands dapagliflozin indication to reduce heart failure hospitalization

October 21, 2019
The diabetes drug dapagliflozin has been approved by the FDA to reduce the risk for heart failure hospitalization among adults with type 2 diabetes who also have…
Meeting News

Top takeaways from CMHC 2019

October 19, 2019
Endocrine Today has compiled a list of the top five news reports posted from the Cardiometabolic Health Congress, held from Oct. 10 to 13 in Chicago…
In the Journals

Angiotensin receptor blockers may increase risk for suicide

October 16, 2019
Patients treated with angiotensin receptor blockers had an increased risk for suicide compared with those treated with ACE inhibitors, according to a study published in…
More Headlines »
CME CPE

Managing Chronic Heart Failure in Special Populations

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

This activity will address the management of heart failure (HF) in older adults, African Americans, patients with…
More »
Video
Meeting News

VIDEO: Top takeaways from ESC Congress with Dipti Itchhaporia, MD

September 25, 2019
More »
Video
Meeting News

VIDEO: 'Incredible amount of science' presented at ESC Congress

October 7, 2018
More »